These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19135108)

  • 1. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.
    Sakaeda T; Yamamori M; Kuwahara A; Nishiguchi K
    Adv Drug Deliv Rev; 2009 May; 61(5):388-401. PubMed ID: 19135108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
    Tomura K; Kogo M; Inoue T; Kaneko K; Imawari M; Yoneyama K; Kiuchi Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1807-13. PubMed ID: 18030014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation in the management of esophageal cancer.
    Kleinberg L; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(26):4110-7. PubMed ID: 17827461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
    Nishiyama M; Eguchi H
    Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
    Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S
    Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
    Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
    Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
    Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal cancer: current and emerging therapy modalities.
    Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An appropriate chemotherapy for esophageal cancer from a histological standpoint].
    Hayashi K; Nakamura T; Narumiya K; Yamamoto M
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):182-6. PubMed ID: 19223733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression changes in a chemoresistant model with human esophageal cancer xenografts using cDNA microarray.
    Yoshida T; Miyoshi T; Seike J; Yamai H; Takechi H; Yuasa Y; Tangoku A
    Anticancer Res; 2009 Apr; 29(4):1163-8. PubMed ID: 19414360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
    Lehne G; Bjørheim J; Saeter G
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
    Maher SG; Gillham CM; Duggan SP; Smyth PC; Miller N; Muldoon C; O'Byrne KJ; Sheils OM; Hollywood D; Reynolds JV
    Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
    Morita M; Masuda T; Okada S; Yoshinaga K; Saeki H; Tokunaga E; Endo K; Emi Y; Kakeji Y; Maehara Y
    Anticancer Res; 2009 Jul; 29(7):2555-62. PubMed ID: 19596928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variability of pharmacokinetics of 5-fluorouracil and CLOCK T3111C genetic polymorphism in patients with esophageal carcinoma.
    Miki I; Tamura T; Nakamura T; Makimoto H; Hamana N; Uchiyama H; Shirasaka D; Morita Y; Yamada H; Aoyama N; Sakaeda T; Okumura K; Kasuga M
    Ther Drug Monit; 2005 Jun; 27(3):369-74. PubMed ID: 15905809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma].
    Tsuchiya Y; Noguchi T; Matsumoto K; Matsumura T; Hoshi K; Ito H; Osano H; Jinbu Y; Kusama M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):101-3. PubMed ID: 19151572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma].
    Yang H; Fu JH; Hu Y; Lin P; Liu MZ; Li Q; Fang ZC; Hu YH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(45):3182-5. PubMed ID: 19171088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in cancer chemotherapy: current strategies, pharmacokinetics, and pharmacogenomics.
    Nishiyama M; Eguchi H
    Adv Drug Deliv Rev; 2009 May; 61(5):367-8. PubMed ID: 19154764
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
    Marsh S; Liu G
    Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.